[go: up one dir, main page]

ZA899802B - Use of l-carnitine derivatives in the therapeutic treatment of degenerative alterations of the nervous system - Google Patents

Use of l-carnitine derivatives in the therapeutic treatment of degenerative alterations of the nervous system

Info

Publication number
ZA899802B
ZA899802B ZA899802A ZA899802A ZA899802B ZA 899802 B ZA899802 B ZA 899802B ZA 899802 A ZA899802 A ZA 899802A ZA 899802 A ZA899802 A ZA 899802A ZA 899802 B ZA899802 B ZA 899802B
Authority
ZA
South Africa
Prior art keywords
nervous system
therapeutic treatment
carnitine derivatives
degenerative alterations
alterations
Prior art date
Application number
ZA899802A
Other languages
English (en)
Inventor
Claudio Cavazza
Cavazza Claudio
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ZA899802B publication Critical patent/ZA899802B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA899802A 1988-12-27 1989-12-21 Use of l-carnitine derivatives in the therapeutic treatment of degenerative alterations of the nervous system ZA899802B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8848717A IT1224842B (it) 1988-12-27 1988-12-27 Uso di derivati della l-carnitina nel trattamento terapeutico delle alterazioni degenerative del sistema nervoso

Publications (1)

Publication Number Publication Date
ZA899802B true ZA899802B (en) 1990-11-28

Family

ID=11268228

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA899802A ZA899802B (en) 1988-12-27 1989-12-21 Use of l-carnitine derivatives in the therapeutic treatment of degenerative alterations of the nervous system

Country Status (9)

Country Link
US (1) US5043355A (xx)
EP (1) EP0376899B1 (xx)
JP (1) JP2828293B2 (xx)
AT (1) ATE92316T1 (xx)
DE (1) DE68908145T2 (xx)
ES (1) ES2058596T3 (xx)
HK (1) HK1005849A1 (xx)
IT (1) IT1224842B (xx)
ZA (1) ZA899802B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245699B (it) * 1991-05-29 1994-10-14 Sigma Tau Ind Farmaceuti Derivati della l-carnitina quali agenti terapeutici per il trattamento delle miopatie, della degenarazione neuronale e per inibire la proteolisi
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1277898B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
PT951909E (pt) 1998-03-19 2004-04-30 Sigma Tau Ind Farmaceuti Composicao combinada que contem uma l-carnitina ou uma alcanoil-l-carnitina um glicosaminoglicano e/ou um seu constituinte
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
ITRM20040327A1 (it) * 2004-07-01 2004-10-01 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina per la preparazione di un medicamento per il trattamento del dolore neuropatico in pazienti diabetici.
WO2007043339A1 (en) * 2005-09-30 2007-04-19 Showa Denko K.K. Carnitine derivative, salt thereof, external skin preparation and cosmetic material
JP5047507B2 (ja) * 2005-09-30 2012-10-10 昭和電工株式会社 カルニチン誘導体及びその塩、皮膚外用剤ならびに化粧料
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
US20200129464A1 (en) * 2018-10-29 2020-04-30 Lonza Inc. Method and Composition for Increasing the Bioavailability of Carnitine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903579A1 (de) * 1978-02-03 1979-08-09 Sigma Tau Ind Farmaceuti Verwendung von acetylcarnitin und anderen acylderivaten des carnitins zur behandlung der hyperlipoproteinaemie und hyperlimpidaemie sowie arzneimittel
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
IT1206954B (it) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1150396B (it) * 1982-12-09 1986-12-10 Sigma Tau Ind Farmaceuti Impiego di alcanoil l-carnitine per il trattamento terapeutico di miopa tie e distrofie muscolari
IT1181682B (it) * 1985-06-11 1987-09-30 Sigma Tau Ind Farmaceuti Impiego di alcanoil l-carnitine per il trattamento terapeutico del parkinsonismo idiopatico o indotto
IT1208753B (it) * 1986-07-02 1989-07-10 Sigma Tau Ind Farmaceuti L-amminoacil derivati della l-carnitina, procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' epatoprotettrice che li contengono
IT1196564B (it) * 1986-08-04 1988-11-16 Sigma Tau Ind Farmaceuti Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche

Also Published As

Publication number Publication date
ATE92316T1 (de) 1993-08-15
DE68908145D1 (de) 1993-09-09
JPH02207020A (ja) 1990-08-16
IT8848717A0 (it) 1988-12-27
EP0376899A3 (en) 1991-09-18
JP2828293B2 (ja) 1998-11-25
ES2058596T3 (es) 1994-11-01
DE68908145T2 (de) 1993-11-25
EP0376899B1 (en) 1993-08-04
HK1005849A1 (en) 1999-01-29
US5043355A (en) 1991-08-27
EP0376899A2 (en) 1990-07-04
IT1224842B (it) 1990-10-24

Similar Documents

Publication Publication Date Title
ZA899802B (en) Use of l-carnitine derivatives in the therapeutic treatment of degenerative alterations of the nervous system
ZA944739B (en) Amide and urea derivatives having anti-hypercholesteremic activity their preparation and their therapeutic uses
PH23867A (en) Method of treating parkinson's disease using indolone derivatives
CA2029420A1 (en) Pharmaceutical compositions and methods for inhibition of maillard's reaction
EP0347252A3 (en) Method of treating cachexia and certain new compounds for use in this method
HK78193A (en) Preparations for the treatment of mycoplasmoses and bacterial infections in poultry
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
HK1006284A1 (en) Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use
NZ216334A (en) Spiro imidazolone derivatives and pharmaceutical composition
EP0231087A3 (en) Heptanoyl-glu-asp-ala-amino acid immunostimulants
HUT70757A (en) Pharmaceutical compositions for treating skin disorders
ZA895387B (en) Novel s-adenosyl methionine decarboxylase inhibitors
NO933091L (no) Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser
ES2012958A6 (es) Procedimiento para preparar derivados de cisteina.
HUT52044A (en) Process for producing pyrrolidine derivatives
ZA892258B (en) Use of isoxazolinones as cerebro-active drugs
EP0322248A3 (en) Compounds effective against cerebral insufficiency